Butabarbital decreases results of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Closely. Coadministration of CYP3A4 inducers may perhaps reduce sufentanil amounts and efficacy, quite possibly precipitating withdrawal syndrome in patients which have made Bodily dependence to sufentanil. Discontinuation of concomitantly used CYP3A4 induce... https://jamesm741efe0.cosmicwiki.com/user